PANCREATIN
Natural health product licensed in Canada
- Other names
- KONIG PANCREATIN, KONIG PANCREATIN 1300, PANCREATIN 1300
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80043562
- Status
- Active licence
- Licence date
- 12 July 2013
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
farine de riz, Stéarate de magnésium, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have pancreatitis, pancreatic exocrine insufficiency or cystic fibrosis Consulta a helath care practitioner prior to use if you are preagnant or breastfeeding. If symptoms persist or worsen, consult a health care practitioner.
- Contre-indications
Do not use if you are sensitive to pancreatic enzymes. Do not use if you are sensitive to pork proteins.
- Effets indésirables connus
Nausea, vomiting, abdominal pain/epigastric pain and/or heartburn have been known to occur, in which case discontinue use.
Source
Official Health Canada record, licence 80043562
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.